MERCK SHARP & DOHME

Aurobindo Pharma unit inks pact with MSD to enter contract manufacturing operations

​Aurobindo Pharma on Friday said its unit TheraNym Biologics has inked a pact with MSD to set up a plant as it looks to enter the contract manufacturing operations for biologicals. TheraNym Biologics, a wholly-owned subsidiary of Aurobindo Pharma and an affiliate of CuraTeQ, has inked a Master Service Agreement (MSA) with MSD effective today.